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background:  Right Ventricular Apical (RVA) pacing causes a non-physiological activation of the myocardium and can be associated 
with clinical complications. Clinical evidence supporting a benefit to pacing in alternative RV sites is conflicted. The present study was 
undertaken using conductance catheters to assess comprehensive load independent hemodynamic function of both ventricles when pacing 
the heart from two differing sites, the RVA and the RV high septum (RVHS).
Methods:  15 patients (49 ±11 years, 12 men) with structurally normal hearts underwent simultaneous conductance catheterisation of the 
RV and LV. Pressure-volume loops were acquired at end expiration whilst pacing from firstly the RVA and secondly the RVHS.
results: Systolic measures of function in either chamber did not show significant variance between pacing site apart from LVSW, however 
measures of both LV and RV relaxation showed deterioration when pacing was moved from the RVA to the RVHS, (RV Tau from 70.86 
±17.65 to 83.77 ±21.03 P=0.003, RV dP/dT min from -189.41 ±38.68 to -171.06 ±37.27 P=0.05)(LV Tau from 44.40 ±9.99 to 46.70±8.86 
P=0.03, LV dP/dT min from -11155 ±302 to -1422 ±198 P=0.03).
Conclusion:  In our study we demonstrate no significant benefit in systolic function to alternative site pacing at the RVHS compared to 
the RVA and significant deterioration in ventricular relaxation when pacing at the RVHS. This supports previous clinical studies which have 
failed to show any conclusive clinical benefit to non-apical RV pacing.
Pacing states P-value
Variable DDDapex DDDseptum
RV SW (mmHg*V) 863 ±433 910.98 ± 481 0.51
RV CO (V/min) 6437 ±2615 6624 ± 2884 0.68
RV SV (V) 61.24 ±20.42 63.32 ± 25.20 0.62
RV Ves (V) 61.44 ±27.91 63.87 ± 33.41 0.7
RV Ved V (V) 99.06 ±33.67 97.85 ±40.23 0.8
RV Pmax (mmHg) 28.23 ±4.88 28.18 ±5.09 0.94
RV Heart rate (BPM) 104.02 ±14.03 103.9 13.93 0.71
RV EF (%) 63.79 ±12.93 65.17 ±18.15 0.8
RV Ea (mmHg/V) 0.43 ±0.18 0.44 ±0.21 0.83
RV dP/dt max (mmHg/s) 311 ±91.6 301.11 ±85.15 0.44
RV dP/dt min (mmHg/s) -189.41 ±38.68 -171.06 ±37.27 0.05
RV Tau (ms) 70.86 ±17.65 83.77 ±21.03 0.003
RV ESPVR 0.34 ±0.15 0.36 ±0.21 0.48
RV EDPVR 0.09 ±0.04 0.17 ±0.21 0.25
RV PRSW 11.86 ±10.69 12.01 ±3.32 0.98
LV SW (mmHg*V) 4720 ± 2010 3820 ±2208 0.05
LV CO (V/min) 6418 ±2651 6128 ±3798 0.61
LV SV (V) 62.33 ±23.21 58.08 ±28.80 0.42
LV Ves (V) 60.64 ±30.27 60.93 ±32.51 0.99
LV Ved V (V) 95.61 ±39.59 100.17 ±42.15 0.70
LV Pmax (mmHg) 123.88 ±17.53 120.50 ±14.30 0.34
LV Heart rate (BPM) 102.9 ±13.52 102.80 ±13.03 0.64
LV EF (%) 58.12 ±10.45 57.72 ±14.01 0.88
LV Ea (mmHg/V) 2.37 ±1.30 2.50 ±1.19 0.61
LV dP/dt max (mmHg/s) 1534 ±255 1560 ±217 0.43
LV dP/dt min (mmHg/s) -1555 ±302 -1422 ±198 0.04
LV Tau (ms) 44.40 ±9.99 46.70 ±8.86 0.03
LV ESPVR 1.28 ±0.64 1.52 ±1.10 0.29
LV EDPVR 0.21 ±0.16 0.23 ±0.16 0.958
LV PRSW 69.89 ±37.47 55.11 ±20.34 0.20
P-values have been obtained from a permutation test using 1000000 samples
